The global monoclonal antibody market is booming, but outdated analytical tools can delay the drug discovery race to be the first to deliver to patients. Faster, automated tools such as capillary ...
Upstream Process Development (UPD) is essential to ensure robust, scalable processes that can efficiently bring biotherapeutics to market. However, challenges such as optimizing yield, ensuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback